Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated Aug 14, 2019. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q2 2019. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 22.3B USD
- Positions
- 59
- Share of the ten largest
- 54.0%
The ten largest positions Q2 2019
- Adaptive Biotechnologies Cor 8.3%new
- Amazon 6.8%▲ +157.6%
- Elevance Health 6.6%▼ −16.1%
- Meta Platforms 6.1%▲ +231.7%
- UnitedHealth Group 5.3%▲ +28.6%
- Microsoft 4.6%▼ −21.2%
- Boeing 4.5%new
- JD.com (ADR) 4.3%▲ +175.5%
- United Technologies Corp 3.9%▼ −4.8%
- Netflix 3.4%▲ +3.4%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q2 2019
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| AMZN Amazon | 6.8% | 802,837 | 1.5B USD | +157.6% increased | Q2 2015 17 quarters |
| NFLX Netflix | 3.4% | 2,067,698 | 759.5M USD | +3.4% increased | Q3 2015 16 quarters |
| GOOGL Alphabet Inc. (Class A) | 1.4% | 282,146 | 305.5M USD | −24.7% reduced | Q4 2015 15 quarters |
| META Meta Platforms | 6.1% | 7,063,705 | 1.4B USD | +231.7% increased | Q1 2016 14 quarters |
| Editas Medicine Inc | 0.1% | 931,401 | 23.0M USD | unchanged | Q1 2016 14 quarters |
| MSFT Microsoft | 4.6% | 7,704,063 | 1.0B USD | −21.2% reduced | Q2 2016 13 quarters |
| V Visa Inc. | 0.3% | 387,368 | 67.2M USD | −87.4% reduced | Q3 2016 12 quarters |
| UNH UnitedHealth Group | 5.3% | 4,812,185 | 1.2B USD | +28.6% increased | Q4 2016 11 quarters |
| Liberty Media Corp Delaware | 1.9% | 11,379,423 | 425.7M USD | −2.5% reduced | Q1 2017 10 quarters |
| ELV Elevance Health | 6.6% | 5,198,006 | 1.5B USD | −16.1% reduced | Q2 2017 9 quarters |
| United Technologies Corp | 3.9% | 6,743,903 | 878.1M USD | −4.8% reduced | Q3 2017 8 quarters |
| Atyr Pharma Inc | < 0.1% | 3,209,955 | 1.2M USD | unchanged | Q3 2017 8 quarters |
| Biomarin Pharmaceutical Inc | 1.0% | 2,590,351 | 221.9M USD | −49.5% reduced | Q1 2018 6 quarters |
| BABA Alibaba Group (ADR) | 0.4% | 587,268 | 99.5M USD | −89.8% reduced | Q1 2018 6 quarters |
| Syneos Health Inc | 0.4% | 1,796,775 | 91.8M USD | −19.0% reduced | Q1 2018 6 quarters |
| Catalent Inc | 0.4% | 1,595,579 | 86.5M USD | +50.5% increased | Q1 2018 6 quarters |
| Anaptysbio Inc | 0.2% | 799,897 | 45.1M USD | −3.6% reduced | Q1 2018 6 quarters |
| CNC Centene Corporation | 3.3% | 13,994,550 | 733.9M USD | +233.3% increased | Q2 2018 5 quarters |
| ILMN Illumina, Inc. | 2.3% | 1,371,087 | 504.8M USD | +16.0% increased | Q2 2018 5 quarters |
| Eidos Therapeutics Inc | 0.1% | 882,353 | 27.4M USD | −55.6% reduced | Q2 2018 5 quarters |
| BSX Boston Scientific | 1.8% | 9,195,192 | 395.2M USD | +185.5% increased | Q3 2018 4 quarters |
| Exact Sciences Corp | 1.2% | 2,264,674 | 267.3M USD | −29.6% reduced | Q3 2018 4 quarters |
| AON Aon plc | 0.7% | 851,778 | 164.4M USD | +30.2% increased | Q3 2018 4 quarters |
| Berry Global Group Inc | 0.4% | 1,804,817 | 94.9M USD | −76.6% reduced | Q3 2018 4 quarters |
| Blueprint Medicines Corp | 0.2% | 551,040 | 52.0M USD | −16.3% reduced | Q3 2018 4 quarters |
| ADBE Adobe Inc. | 1.6% | 1,214,269 | 357.8M USD | −40.5% reduced | Q4 2018 3 quarters |
| ALGN Align Technology | 1.4% | 1,161,145 | 317.8M USD | −35.3% reduced | Q4 2018 3 quarters |
| DVA DaVita | 0.7% | 2,907,034 | 163.6M USD | +5.5% increased | Q4 2018 3 quarters |
| GOOG Alphabet Inc. (Class C) | 0.6% | 114,172 | 123.4M USD | −17.1% reduced | Q4 2018 3 quarters |
| MRNA Moderna | 0.5% | 8,197,458 | 120.0M USD | −50.8% reduced | Q4 2018 3 quarters |
| Wellcare Health Plans Inc | 0.5% | 371,450 | 105.9M USD | −71.9% reduced | Q4 2018 3 quarters |
| JD JD.com (ADR) | 4.3% | 31,821,898 | 963.9M USD | +175.5% increased | Q1 2019 2 quarters |
| MELI MercadoLibre | 2.3% | 854,831 | 523.0M USD | +39.7% increased | Q1 2019 2 quarters |
| Activision Blizzard Inc | 1.7% | 7,908,859 | 373.3M USD | +61.1% increased | Q1 2019 2 quarters |
| MU Micron Technology | 1.1% | 6,431,167 | 248.2M USD | +180.9% increased | Q1 2019 2 quarters |
| Axa Equitable HLDGS Inc | 0.8% | 8,842,350 | 184.8M USD | +1,197.3% increased | Q1 2019 2 quarters |
| Crown Holdings Inc | 0.6% | 2,293,475 | 140.1M USD | +13.2% increased | Q1 2019 2 quarters |
| NVDA Nvidia | 0.6% | 802,330 | 131.8M USD | −57.4% reduced | Q1 2019 2 quarters |
| Covetrus Inc | 0.4% | 3,381,937 | 82.7M USD | −13.1% reduced | Q1 2019 2 quarters |
| NXPI NXP Semiconductors | 0.3% | 670,065 | 65.4M USD | −75.4% reduced | Q1 2019 2 quarters |
| Adaptive Biotechnologies Cor | 8.3% | 38,406,607 | 1.9B USD | new | Q2 2019 1 quarter |
| BA Boeing | 4.5% | 2,777,120 | 1.0B USD | new | Q2 2019 1 quarter |
| Bridgebio Pharma Inc | 3.2% | 26,620,991 | 718.0M USD | new | Q2 2019 1 quarter |
| UBER Uber | 2.8% | 13,368,682 | 620.0M USD | new | Q2 2019 1 quarter |
| MNST Monster Beverage | 2.5% | 8,851,947 | 565.0M USD | new | Q2 2019 1 quarter |
| CRM Salesforce | 2.0% | 2,922,394 | 443.4M USD | new | Q2 2019 1 quarter |
| Avantor Inc | 1.0% | 11,345,684 | 216.6M USD | new | Q2 2019 1 quarter |
| XYZ Block, Inc. | 0.9% | 2,657,236 | 192.7M USD | new | Q2 2019 1 quarter |
| Slack Technologies Inc | 0.8% | 4,539,615 | 170.2M USD | new | Q2 2019 1 quarter |
| LOW Lowe's | 0.6% | 1,381,012 | 139.4M USD | new | Q2 2019 1 quarter |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 longest-held of 59 positions.
Breakdown by sector
- Health Care 21.9%
- Communication Services 11.5%
- Technology 10.2%
- Industrials 7.8%
- Consumer Discretionary 7.4%
- Consumer Staples 2.5%
- Financials 2.2%
- not in our coverage 36.4%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors